Neuroendocrine Response to Critical Illness

Critical illness results in a number of alterations in the hypothalamic-anterior pituitary-peripheral hormone axes. In this issue, an international pool of experts covers the latest information regarding the neuroendocrine response to critical illness, including changes within the thyroid axis, dyslipidemia in the critically ill, relative adrenal failure in the intensive care unit (ICU), cathecholamines and vasopressin during critical illness, gonadal steroids in critical illness, glucose metabolism and insulin therapy, treatment with Growth Hormone and IGF-1 in critical illness, and changes within the Growth Hormone/IGF-1/IGF-BP Axis.